These findings demonstrate that overexpression of NCL inhibits CD8+ T cell glucose metabolism in vivo by alleviating MYC-mediated transcriptional repression of TXNIP, thereby weakening their infiltration capability in the tumor microenvironment and anti-tumor immunity, ultimately promoting tumor growth. The gene discussed is CD8A; the disease is neoplasm.